Related Experiment Video
Updated: Apr 28, 2026

03:26
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
4.2K
Botulinum Toxin as Targeted Neuromodulation in Complex Regional Pain Syndrome: An Anatomy-Informed Mechanistic Review
1Department of Rehabilitation Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Toxins
|April 27, 2026
Summary
Botulinum toxin’s effectiveness for complex regional pain syndrome (CRPS) depends on targeted delivery. Direct delivery to affected neural structures shows consistent therapeutic signals, unlike non-specific methods.
Area of Science:
- Neurology
- Pain Medicine
- Pharmacology
Background:
- Complex regional pain syndrome (CRPS) is a debilitating chronic pain condition with complex neuroplasticity.
- The clinical utility of botulinum toxin for CRPS is debated due to inconsistent study outcomes.
Purpose of the Study:
- To reconcile conflicting findings on botulinum toxin efficacy in CRPS.
- To propose an anatomy-informed framework for botulinum toxin application in CRPS.
Main Methods:
- Synthesis of mechanistic, translational, and clinical evidence.
- Integration of experimental data, randomized trials, and case-based evidence.
- Development of an anatomy-informed, route-specific neuromodulation framework.
Main Results:
- Inconsistent outcomes may stem from varied anatomical targeting and administration routes.
- Direct delivery to sympathetic nervous system and proximal somatic afferents shows more consistent therapeutic signals.
- Superficial or non-specific delivery methods result in more variable responses.
Conclusions:
- Botulinum toxin efficacy in CRPS is likely dependent on precise anatomical targeting.
- An anatomy-informed framework can guide rational trial design and clinical application of botulinum toxin.
- Future research should focus on phenotype-aligned, targeted delivery strategies for CRPS treatment.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
2.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
2.2K
Analgesia and Pain Management
3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K

